Back
Sensei Biotherapeutics 10K Form
Sell
46
SNSE
Sensei Biotherapeutics
Last Price:
0.50
Seasonality Move:
-0.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SNSE News And Ratings
See the #1 stock for the next 7 days that we like better than SNSE
SNSE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-5.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.08 |
| Price / Book: | 0.24 |
Profitability
| EPS (TTM): | -1.18000 |
|---|---|
| Net Income (TTM): | $-29.67M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Sensei Biotherapeutics Earnings Forecast
Key Sensei Biotherapeutics Financial Ratios
- The Interest Expense is -0.42% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Sensei Biotherapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SNSE |
| Website: | senseibio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SNSE Technical Analysis vs Fundamental Analysis
Sell
46
Sensei Biotherapeutics (SNSE)
is a Sell
Is Sensei Biotherapeutics a Buy or a Sell?
-
Sensei Biotherapeutics stock is rated a Sell
The current Sensei Biotherapeutics [SNSE] share price is $0.49. The Score for SNSE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.